These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36856148)

  • 21. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis.
    Rastogi A; Fishbane S; Lerma E
    Expert Rev Clin Pharmacol; 2023 May; 16(5):387-400. PubMed ID: 37010031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
    Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
    J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
    Mathur VS; Kumar J; Crawford PW; Hait H; Sciascia T;
    Am J Nephrol; 2017; 46(6):450-458. PubMed ID: 29253847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
    N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.
    Fishbane S; Mathur V; Germain MJ; Shirazian S; Bhaduri S; Munera C; Spencer RH; Menzaghi F;
    Kidney Int Rep; 2020 May; 5(5):600-610. PubMed ID: 32405581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial.
    Akuta N; Kumada H; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Suzuki F; Arase Y; Ikeda K
    Hepatol Res; 2018 Sep; 48(10):810-813. PubMed ID: 29601141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uremic pruritus.
    Mettang T; Kremer AE
    Kidney Int; 2015 Apr; 87(4):685-91. PubMed ID: 24402092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difelikefalin: A New κ-Opioid Receptor Agonist for the Treatment of Hemodialysis-Dependent Chronic Kidney Disease-Associated Pruritus.
    Fugal J; Serpa SM
    Ann Pharmacother; 2023 Apr; 57(4):480-488. PubMed ID: 35942600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of sertraline in alleviating uremic pruritus in hemodialysis patients: a randomized clinical trial.
    Elsayed MM; Elgohary IE; Abdelhamid HHS; Zaki SA
    BMC Nephrol; 2023 Jun; 24(1):155. PubMed ID: 37270517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difelikefalin for Hemodialysis Patients with Pruritus in Japan.
    Narita I; Tsubakihara Y; Takahashi N; Ebata T; Uchiyama T; Marumo M; Okamura S; Gejyo F;
    NEJM Evid; 2023 Nov; 2(11):EVIDoa2300094. PubMed ID: 38320524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study.
    Aramwit P; Keongamaroon O; Siritientong T; Bang N; Supasyndh O
    BMC Nephrol; 2012 Sep; 13():119. PubMed ID: 23006933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pruritus in systemic diseases : Common and rare etiologies].
    Kremer AE; Mettang T
    Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study.
    Gholyaf M; Sheikh V; Yasrebifar F; Mohammadi Y; Mirjalili M; Mehrpooya M
    Int Urol Nephrol; 2020 Jun; 52(6):1155-1165. PubMed ID: 32383050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pruritus-reducing effects of omega-3 fatty acids in hemodialysis patients: A cross-over randomized clinical trial.
    Forouhari A; Moghtaderi M; Raeisi S; Shahidi S; Parin Hedayati Z; Zaboliyan J; Ani S; Moeinzadeh F; Mortazavi M
    Hemodial Int; 2022 Jul; 26(3):408-414. PubMed ID: 35112475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pruritus in systemic diseases : Common and rare etiologies].
    Kremer AE; Mettang T
    Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial for effectiveness of zolpidem versus acupressure on sleep in hemodialysis patients having chronic kidney disease-associated pruritus.
    Rehman IU; Wu DB; Ahmed R; Khan NA; Rahman AU; Munib S; Lee LH; Chan KG; Khan TM
    Medicine (Baltimore); 2018 Aug; 97(31):e10764. PubMed ID: 30075491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease-associated pruritus in patients undergoing hemodialysis: Xerosis and topical therapy.
    Krismi A; Danarti R; Setiabudi IIDPP; Wirohadidjojo YW
    Hemodial Int; 2023 Apr; 27(2):91-104. PubMed ID: 36811513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nalfurafine hydrochloride for the treatment of pruritus.
    Inui S
    Expert Opin Pharmacother; 2012 Jul; 13(10):1507-13. PubMed ID: 22663138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Opioid Pathway for Uremic Pruritus: A Systematic Review and Meta-analysis.
    Jaiswal D; Uzans D; Hayden J; Kiberd BA; Tennankore KK
    Can J Kidney Health Dis; 2016; 3():2054358116675345. PubMed ID: 28270926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One year long-term study on abuse liability of nalfurafine in hemodialysis patients.
    Ueno Y; Mori A; Yanagita T
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):823-31. PubMed ID: 24040851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.